OTCMKTS:RADLY Raia Drogasil (RADLY) Stock Price, News & Analysis $3.72 +0.10 (+2.76%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendShort InterestBuy This Stock About Raia Drogasil Stock (OTCMKTS:RADLY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Raia Drogasil alerts:Sign Up Key Stats Today's Range$3.72▼$4.0550-Day Range$3.62▼$4.9752-Week Range$2.17▼$5.34Volume6,486 shsAverage Volume17,445 shsMarket Capitalization$4.89 billionP/E RatioN/ADividend Yield0.81%Price TargetN/AConsensus RatingHold Company Overview Raia Drogasil S.A. is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring. The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades. Headquartered in São Paulo, Raia Drogasil has expanded its footprint to all regions of Brazil, with a particularly strong presence in the Southeastern and Northeastern states. This broad geographic coverage positions the company to capture growth in densely populated metropolitan markets as well as emerging local communities. In response to evolving consumer preferences, Raia Drogasil has developed digital platforms that support online ordering, home delivery and click-and-collect services. The company has also launched a loyalty program that rewards frequent shoppers with discounts, personalized promotions and health-oriented content. These initiatives complement its physical retail network, enhancing customer convenience and fostering deeper engagement. Raia Drogasil continues to invest in supply chain optimization and partnerships with pharmaceutical and consumer goods suppliers to broaden its product portfolio. The company’s management emphasizes operational efficiency, store modernization and the integration of digital tools, aiming to reinforce its position as Brazil’s foremost pharmacy chain and to meet the evolving needs of Brazilian consumers. AI Generated. May Contain Errors. Read More Receive RADLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Raia Drogasil and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RADLY Stock News HeadlinesRaia Drogasil S.A. (RADLY) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comRaia Drogasil S.A. (RADLY) Q4 2025 Earnings Call TranscriptMarch 6, 2026 | seekingalpha.comFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the biggest story of his 26-year career - an economic shift not seen since 1776. From the government taking stakes in Intel, Lithium Americas, and MP Materials, to sweeping political changes reshaping the economy, Stansberry argues a rare 'New 1776 Moment' is already underway. One Nobel Prize winner calls it a dividing line for all of society. His presentation covers the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 20 at 1:00 AM | Porter & Company (Ad)Raia Drogasil S.A. (RADLY) Q3 2025 Earnings Call TranscriptNovember 6, 2025 | seekingalpha.comBrazil’s Battered Stocks Could Rebound, but Not Before the Presidential VoteJuly 8, 2022 | finance.yahoo.comRaia Drogasil SA ADR (RADLY)May 4, 2022 | uk.investing.comSee More Headlines RADLY Stock Analysis - Frequently Asked Questions How have RADLY shares performed this year? Raia Drogasil's stock was trading at $4.6520 on January 1st, 2026. Since then, RADLY shares have decreased by 20.0% and is now trading at $3.72. When did Raia Drogasil's stock split? Raia Drogasil's stock split on the morning of Monday, May 22nd 2023.The 26-25 split was announced on Monday, May 22nd 2023. The newly issued shares were payable to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split. How do I buy shares of Raia Drogasil? Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/20/2026Next Earnings (Estimated)8/04/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:RADLY CIKN/A Webwww.rd.com.br Phone551137695678FaxN/AEmployees57,708Year Founded2011Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,315,247,000Free FloatN/AMarket Cap$4.89 billion OptionableNot Optionable BetaN/A Social Links 5G Stocks: The Path Forward is ProfitableClick the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (OTCMKTS:RADLY) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredMusk's acquisition pattern points to ONE stockMusk needed solar - he acquired SolarCity. Needed data - he bought Twitter. The pattern is clear: when a suppl...Behind the Markets | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredWhy most traders are always one step behindMost traders do not lose because they are unlucky - they lose because they are late. Chasing moves that have a...Base Camp Trading | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredMissed Nvidia’s 44,000%? This is the next big opportunityIn February 2016, Louis Navellier recommended Nvidia at $2.51 split-adjusted - before a 44,000% gain. He also ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Raia Drogasil S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Raia Drogasil With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
